IFNG and colorectal carcinoma: Accordingly, exposure to persistent IFN-γ signaling can cause tumors to acquire immune resistance and increase the expression of immunosuppressive molecules, and INF-γ merits additional investigation as a potential predictive biomarker for the efficacy of immunotherapy in CRC (111, 112).